Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	809	406	108	125	256	297
Market Cap Growth	450.37%	277.18%	-14.15%	-50.96%	-14.02%	15.84%
Enterprise Value	752	377	85	117	226	284
Last Close Price	10.12	5.30	1.43	1.68	3.74	4.80
PE Ratio	47.02	47.50	-	-	-	-
Forward PE	67.47	50.28	-	-	-	-
PS Ratio	6.74	4.08	1.29	1.74	3.79	5.02
PB Ratio	12.57	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	12.65	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	38.64	33.99	15.45	-	-	-
P/OCF Ratio	38.13	33.54	15.13	-	-	-
EV/Sales Ratio	6.46	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	43.08	44.12	-	-	-	-
EV/EBIT Ratio	45.10	48.76	-	-	-	-
EV/FCF Ratio	35.91	31.54	12.17	-	-	-
Debt / Equity Ratio	0.05	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.18	0.27	-	-	-	-
Debt / FCF Ratio	0.16	0.22	0.47	-	-	-
Asset Turnover	1.60	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.27	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.16	2.96	1.57	1.61	1.89	1.17
Current Ratio	3.88	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	37.36%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	14.31%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Capital (ROIC)	20.56%	12.00%	-10.82%	-33.57%	-62.10%	-61.70%
Return on Capital Employed (ROCE)	24.10%	15.40%	-	-	-	-
Earnings Yield	2.19%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	2.59%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-10.13%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q